COLTENE Holding AG (CLHLF) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist COLTENE Holding AG (CLHLF) ein Healthcare-Unternehmen mit einer Bewertung von 0. Bewertet mit 49/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026COLTENE Holding AG (CLHLF) Gesundheitswesen & Pipeline-Uebersicht
COLTENE Holding AG, a Swiss-based company, develops and markets a comprehensive portfolio of dental supplies and equipment, including restoratives, endodontics, and prosthetics. With a global presence and a focus on innovation, COLTENE serves dentists and dental laboratories across Europe, the Americas, and Asia/Oceania, holding a significant position in the dental consumables market.
Investmentthese
COLTENE Holding AG presents a notable research candidate within the dental supplies market. The company's diversified product portfolio, global reach, and focus on innovation provide a solid foundation for growth. With a P/E ratio of 18.85 and a dividend yield of 5.30%, COLTENE offers a balance of value and income potential. Ongoing catalysts include increasing demand for advanced dental materials and equipment, particularly in emerging markets. Potential risks include competition from larger players in the dental industry and fluctuations in currency exchange rates. The company's ability to maintain its profit margin of 6.2% and gross margin of 46.2% will be crucial for sustained profitability.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $0.37 billion, reflecting the company's established position in the dental supplies market.
- P/E ratio of 18.85, suggesting a reasonable valuation compared to its earnings.
- Dividend yield of 5.30%, offering an attractive income stream for investors.
- Gross margin of 46.2%, indicating efficient cost management in its manufacturing and distribution processes.
- Beta of 0.80, suggesting lower volatility compared to the overall market.
Wettbewerber & Vergleichsunternehmen
Staerken
- Comprehensive product portfolio covering various dental specialties.
- Global distribution network providing access to diverse markets.
- Established brand reputation for high-quality dental products.
- Strong relationships with dental professionals and laboratories.
Schwaechen
- Exposure to currency exchange rate fluctuations.
- Dependence on distributors in certain markets.
- Limited brand recognition compared to larger competitors.
- Higher cost structure compared to some competitors.
Katalysatoren
- Ongoing: Increasing demand for dental consumables in emerging markets.
- Ongoing: Product innovation and development of advanced dental solutions.
- Ongoing: Strategic acquisitions to expand product portfolio and geographic reach.
- Upcoming: Potential regulatory approvals for new dental products in key markets.
- Ongoing: Growth in digital dentistry solutions and adoption by dental professionals.
Risiken
- Potential: Intense competition from established and emerging players in the dental industry.
- Potential: Changes in dental regulations and reimbursement policies affecting product sales.
- Potential: Economic downturns impacting dental care spending and demand for products.
- Ongoing: Exposure to currency exchange rate fluctuations affecting financial performance.
- Potential: Product recalls or liability claims impacting brand reputation and financial results.
Wachstumschancen
- Expansion in Emerging Markets: COLTENE has the opportunity to expand its presence in emerging markets, particularly in Asia and Latin America. These regions are experiencing rapid growth in dental care demand due to increasing disposable incomes and rising awareness of oral hygiene. By establishing strategic partnerships and tailoring its product offerings to local needs, COLTENE can capture a significant share of these growing markets. This expansion could contribute to revenue growth of 10-15% over the next 3-5 years.
- Product Innovation and Development: COLTENE can drive growth through continuous product innovation and development. By investing in research and development, the company can introduce new and improved dental materials and equipment that meet the evolving needs of dental professionals. This includes developing advanced composites, CAD/CAM solutions, and endodontic products. Successful product innovation can lead to increased market share and higher profit margins. Expect to see new products contributing 5-8% to revenue growth annually.
- Strategic Acquisitions: COLTENE can pursue strategic acquisitions to expand its product portfolio and geographic reach. By acquiring complementary businesses, the company can gain access to new technologies, markets, and customer segments. This can accelerate growth and enhance its competitive position. Potential acquisition targets include companies specializing in niche dental products or those with a strong presence in specific geographic regions. Acquisitions could add 8-12% to overall revenue within 2-4 years.
- Digital Dentistry Solutions: COLTENE can capitalize on the growing trend of digital dentistry by developing and offering comprehensive digital solutions. This includes CAD/CAM systems, intraoral scanners, and 3D printers. By providing integrated digital workflows, COLTENE can help dental professionals improve efficiency, accuracy, and patient outcomes. The digital dentistry market is expected to grow significantly in the coming years, presenting a substantial growth opportunity for COLTENE. Expect digital solutions to contribute 10-15% to revenue within 5 years.
- Enhanced Customer Training and Support: COLTENE can strengthen its customer relationships and drive sales by providing enhanced training and support to dental professionals. This includes offering hands-on training courses, online resources, and technical support. By helping customers effectively use its products, COLTENE can increase customer satisfaction and loyalty. This can lead to repeat business and positive word-of-mouth referrals. Improved customer support could increase sales by 5-7% annually.
Chancen
- Expansion in emerging markets with growing dental care demand.
- Development of innovative digital dentistry solutions.
- Strategic acquisitions to expand product portfolio and geographic reach.
- Increased focus on customer training and support.
Risiken
- Intense competition from established and emerging players.
- Changes in dental regulations and reimbursement policies.
- Economic downturns affecting dental care spending.
- Product recalls or liability claims.
Wettbewerbsvorteile
- Established brand reputation for high-quality dental products.
- Comprehensive product portfolio covering various dental specialties.
- Global distribution network providing access to diverse markets.
- Strong relationships with dental professionals and laboratories.
- Intellectual property protection for key products and technologies.
Ueber CLHLF
COLTENE Holding AG, originally incorporated as Medisize Holding AG in 2005 and renamed in 2008, is a global company dedicated to the development, manufacturing, and distribution of dental supplies and equipment. Headquartered in Altstätten, Switzerland, COLTENE serves dentists and dental laboratories worldwide. The company's product portfolio includes a wide array of dental solutions, such as restoration products like composites and CAD/CAM materials, endodontic products including root canal instruments and obturation materials, prosthetics like impression materials, and treatment auxiliaries such as infection control products. COLTENE's evolution has been marked by a focus on innovation and expansion into new markets. The company has strategically developed its product lines to meet the evolving needs of dental professionals, emphasizing high-quality materials and user-friendly designs. COLTENE's global reach extends across Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania, supported by a network of distributors and direct sales teams. With a workforce of 1,176 employees, COLTENE is committed to providing comprehensive solutions that enhance the efficiency and effectiveness of dental practices.
Was das Unternehmen tut
- Develops and manufactures dental restoration products, including composites and bonding agents.
- Offers a range of endodontic solutions, such as root canal files and obturation materials.
- Provides prosthetics products, including impression materials and bite registration systems.
- Manufactures treatment auxiliaries like dental dams, aspirator tips, and cotton products.
- Offers infection control products, including ultrasonic cleaning units and protective barriers.
- Supplies rotary instruments such as burs and polishers for dental procedures.
- Provides laboratory products, including gingiva masks and model-making materials.
Geschaeftsmodell
- Develops and manufactures a wide range of dental products and equipment.
- Sells products directly to dental professionals and laboratories, as well as through distributors.
- Generates revenue through the sale of consumables, tools, and equipment.
- Invests in research and development to innovate and expand its product portfolio.
Branchenkontext
The medical instruments and supplies industry is characterized by continuous innovation and increasing demand for advanced dental solutions. The global dental consumables market is expected to grow, driven by factors such as an aging population, rising disposable incomes, and increasing awareness of oral hygiene. COLTENE Holding AG operates in a competitive landscape that includes established players and emerging companies. Key competitors include AVCTF (Envista Holdings Corporation), BOVNF (Dentsply Sirona), and JNDOF (Straumann). COLTENE differentiates itself through its comprehensive product portfolio, global reach, and focus on high-quality materials.
Wichtige Kunden
- Dentists in private practices.
- Dental laboratories.
- Dental clinics and hospitals.
- Dental distributors and retailers.
Finanzdaten
Chart & Info
COLTENE Holding AG (CLHLF) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
Coltene Holding AG (XSWX:CLTN) Full Year 2025 Earnings Call Highlights: Navigating Challenges ...
Yahoo! Finance: CLHLF News · 21. März 2026
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CLHLF.
Kursziele
Wall-Street-Kurszielanalyse fuer CLHLF.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von CLHLF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Dominik Arnold
CEO
Dominik Arnold serves as the CEO of COLTENE Holding AG. His professional background includes extensive experience in the healthcare industry, with a focus on medical devices and dental solutions. Arnold has held various leadership positions in multinational corporations, contributing to strategic planning, operational efficiency, and market expansion. His expertise spans product development, sales and marketing, and business management. Arnold's leadership is characterized by a commitment to innovation, customer satisfaction, and sustainable growth.
Erfolgsbilanz: Under Dominik Arnold's leadership, COLTENE Holding AG has focused on expanding its global presence and strengthening its product portfolio. Key achievements include the successful launch of innovative dental solutions, strategic acquisitions to enhance market share, and improved operational efficiency. Arnold has also emphasized sustainable business practices and fostering a culture of innovation within the company. His tenure has been marked by consistent revenue growth and increased profitability.
CLHLF OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies do not have to meet minimum listing standards, such as requirements for market capitalization, trading volume, and corporate governance. This lack of regulation and oversight increases the risk associated with investing in these companies.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure increases the difficulty of assessing the company's financial health.
- Low trading volume can lead to price volatility and difficulty in buying or selling shares.
- Lack of regulatory oversight increases the risk of fraud or mismanagement.
- Potential for delisting or trading suspension due to non-compliance with OTC market rules.
- Limited access to company information and management.
- Verify the company's registration and legal status.
- Assess the availability and quality of financial information.
- Evaluate the company's business model and competitive landscape.
- Research the background and experience of the management team.
- Review any available news articles or press releases about the company.
- Consult with a financial advisor to assess the risks and potential rewards.
- Understand the OTC market and its regulations.
- The company has been in operation since 2005, indicating a degree of stability.
- COLTENE Holding AG has a global presence, suggesting a well-established business.
- The company has a significant number of employees (1176), indicating a substantial operation.
- COLTENE Holding AG has a market capitalization of $0.37B, suggesting a relatively large company for the OTC market.
COLTENE Holding AG Aktie: Wichtige Fragen beantwortet
What are the key factors to evaluate for CLHLF?
COLTENE Holding AG (CLHLF) currently holds an AI score of 49/100, indicating low score. Key strength: Comprehensive product portfolio covering various dental specialties.. Primary risk to monitor: Potential: Intense competition from established and emerging players in the dental industry.. This is not financial advice.
How frequently does CLHLF data refresh on this page?
CLHLF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CLHLF's recent stock price performance?
Recent price movement in COLTENE Holding AG (CLHLF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive product portfolio covering various dental specialties.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CLHLF overvalued or undervalued right now?
Determining whether COLTENE Holding AG (CLHLF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CLHLF?
Before investing in COLTENE Holding AG (CLHLF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding CLHLF to a portfolio?
Potential reasons to consider COLTENE Holding AG (CLHLF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Comprehensive product portfolio covering various dental specialties.. Additionally: Global distribution network providing access to diverse markets.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of CLHLF?
Yes, most major brokerages offer fractional shares of COLTENE Holding AG (CLHLF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CLHLF's earnings and financial reports?
COLTENE Holding AG (CLHLF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CLHLF earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- OTC market data may be less reliable than exchange-listed data.
- AI analysis is pending and may provide additional insights.